{"id":"NCT03154125","sponsor":"FHI 360","briefTitle":"Sayana速 Press Extension Study","officialTitle":"A Study to Evaluate the Effectiveness, Pharmacokinetics, Safety, and Acceptability of Sayana速 Press When Injected Every Four Months","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-09-22","primaryCompletion":"2020-05-30","completion":"2020-11-18","firstPosted":"2017-05-16","resultsPosted":"2024-08-30","lastUpdate":"2024-08-30"},"enrollment":750,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"OTHER"},"conditions":["Contraception"],"interventions":[{"type":"DRUG","name":"Sayana速 Press","otherNames":["medroxyprogesterone acetate (MPA) injectable suspension"]}],"arms":[{"label":"Abdomen","type":"EXPERIMENTAL"},{"label":"Upper thigh","type":"EXPERIMENTAL"},{"label":"Back of the upper arm","type":"EXPERIMENTAL"}],"summary":"This is a randomized clinical trial designed to evaluate the effectiveness, safety and acceptability of Sayana速 Press when injected every 4 months (17-18 weeks) for 3 treatment cycles (12 months) of use.","primaryOutcome":{"measure":"Occurrence of Pregnancy","timeFrame":"12 months after treatment initiation","effectByArm":[{"arm":"Abdomen","deltaMin":0,"sd":null},{"arm":"Upper Thigh","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":7,"exclusionCount":13},"locations":{"siteCount":3,"countries":["Brazil","Chile","Dominican Republic"]},"refs":{"pmids":["35483431","35128365"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":355},"commonTop":["Menstruation Irregular","Injection Site Reaction","Amenorrhoea","Weight Decreased","Weight Increased"]}}